Literature DB >> 12805382

Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase.

Wen-Ling Shih1, Min-Liang Kuo, Shuang-En Chuang, Ann-Lii Cheng, Shin-Lian Doong.   

Abstract

We have previously shown that transactivation-proficient hepatitis virus B X protein (HBx) protects Hep 3B cells from transforming growth factor-beta (TGF-beta)-induced apoptosis via activation of the phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling pathway. This work further investigated how HBx activates PI 3-kinase. Src activity was elevated in Hep 3B cells following expression of transactivation-proficient HBx or HBx-GFP fusion proteins. The Src family kinase inhibitor PP2 and C-terminal Src kinase (Csk) both alleviated HBx-mediated PI 3-kinase activation and protection from TGF-beta-induced apoptosis. Therefore, HBx activated a survival signal by linking Src to PI 3-kinase. Systemic subcellular fractionation and membrane flotation assays indicated that approximately 1.5% of ectopically expressed HBxGFP was associated with periplasmic membrane where Src was located. However, neither nucleus-targeted nor periplasmic membrane-targeted HBxGFP was able to upregulate Src activity or to augment PI 3-kinase survival signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805382     DOI: 10.1074/jbc.M302580200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway.

Authors:  Lihong Shen; Xifeng Zhang; Daixi Hu; Tao Feng; Hongli Li; Yongliang Lu; Jiayi Huang
Journal:  Mol Cell Biochem       Date:  2013-08-10       Impact factor: 3.396

2.  Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein.

Authors:  Nicola Fiedler; Ellen Quant; Ludger Fink; Jianguang Sun; Ralph Schuster; Wolfram H Gerlich; Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.

Authors:  Gu-Choul Shin; Hong Seok Kang; Ah Ram Lee; Kyun-Hwan Kim
Journal:  Autophagy       Date:  2016-10-14       Impact factor: 16.016

4.  Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1.

Authors:  Kumiko Ishikawa-Sasaki; Shigeo Nagashima; Koki Taniguchi; Jun Sasaki
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein.

Authors:  Pratibha Gaur; Priya Ranjan; Shipra Sharma; Jenish R Patel; J Bradford Bowzard; Shah K Rahman; Rashmi Kumari; Shivaprakash Gangappa; Jacqueline M Katz; Nancy J Cox; Renu B Lal; Suryaprakash Sambhara; Sunil K Lal
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

6.  Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.

Authors:  Jian Guan; Xiao-Ping Chen; Hong Zhu; Shun-Feng Luo; Bin Cao; Lei Ding
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 7.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

8.  Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.

Authors:  Weihua Li; Xiaohui Miao; Zhongtian Qi; Wenting Zeng; Jianxin Liang; Zengwei Liang
Journal:  Virol J       Date:  2010-02-20       Impact factor: 4.099

9.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

Review 10.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.